Scientist in lab coat reviewing a two-peak HPLC chromatogram to verify a two-component peptide blend for in vitro research
Mindful Research

Sourcing a BPC-157, TB-500 Blend: Two-Component COA and Ratio Verification

Updated By: Mindful Research Team2 min read

Key takeaways

  • A blend COA must verify both peptides independently, not as one combined number.
  • Mass spectrometry should resolve BPC-157 (~1419.5) and TB-500 (~4963) as separate peaks.
  • HPLC purity should be reported per component, and content should confirm the 1:1 ratio.
  • A single peak or single purity figure has not verified a blend.
  • For in vitro research use only.

A credible BPC-157, TB-500 blend COA must confirm both peptides independently—each resolved by mass spectrometry at its expected mass and each quantified by HPLC—so that identity, per-component purity and the stated ratio are all documented, not assumed.

Sourcing a two-component research material adds a verification step over a single peptide: you are confirming two identities in one vial. This guide covers what to look for on a BPC-157, TB-500 certificate of analysis. For research use only.

What should a blend COA show?

  • Two identities by mass. Mass spectrometry should show peaks consistent with BPC-157 (~1419.5 g/mol) and TB-500 (~4963 g/mol) as separate species. The large mass gap makes the two easy to distinguish—see mass spectrometry for peptide identity.
  • Per-component purity by HPLC. A blend complicates a single purity number, so the report should make clear how each peptide’s purity was assessed; how purity is measured by HPLC explains the chromatogram.
  • Content / ratio. The stated masses (e.g. 10 mg / 10 mg) should be supported by a content measurement, confirming the 1:1 ratio rather than inferring it.
  • Endotoxin and net content as for any research peptide.

How do you read it line by line?

Work top to bottom: identity first (both masses present), then purity (per component), then content/ratio, then endotoxin. The general walkthrough in reading a COA line by line applies; the only blend-specific difference is that every identity and purity line should appear twice—once per peptide. A COA that reports a single peak or a single purity figure has not actually verified a blend.

How does this differ from a single-peptide COA?

For a single compound you confirm one mass and one purity value. For the blend you confirm two of each and the ratio between them. The underlying methods are identical; there is just more to check. The single-compound sourcing logic is covered in the BPC-157 structure profile and TB-500 profile.

Related research guides

Research-use note

All materials discussed are supplied for in vitro laboratory research use only, and are not for human or animal use.

Frequently asked questions

How is a BPC-157, TB-500 blend verified on a COA?

A credible COA resolves both peptides by mass spectrometry at their expected masses, reports HPLC purity per component, and confirms the stated 1:1 ratio by content. Mass spectrometry for identity

Can one purity number describe a blend?

Not well; the report should make clear how each peptide's purity was assessed separately rather than giving a single combined figure. HPLC purity explained

How is a blend COA different from a single-peptide COA?

You confirm two identities and two purity values plus the ratio instead of one of each; the methods are the same, there is just more to check. Reading a COA line by line

Continue reading

Two research vials of lyophilized peptide powder beside a volumetric flask and pipette, illustrating in vitro stock concentration preparationBPC-157, TB-500 Blend: Vial Reconstitution and Stock Concentration Math (In Vitro) Reconstituting the 10 mg / 10 mg BPC-157, TB-500 vial in a single aqueous volume gives each peptide its own molar concentration—both sit at... 3D render of two peptide chains side by side, illustrating blend composition and ratio studied in parallel in vitroBPC-157, TB-500 Blend Composition and Ratio: Why Two Peptides Are Studied in Parallel (In Vitro) In the BPC-157, TB-500 blend the two peptides are present at a fixed 1:1 mass ratio (10 mg each in current lots), and... Side-by-side 3D ribbon renders of two thymosin peptides, comparing alpha-1 and beta-4 structures for in vitro researchThymosin Peptides Compared: Alpha-1 vs Beta-4 "Thymosin" names two unrelated research peptides: thymosin alpha-1 (a 28-residue immune-signaling peptide) and thymosin beta-4 / TB-500 (a 43-residue actin-sequestering peptide); they...